Advertisement
Advertisement

BNTX

BNTX logo

BioNTech SE - ADR

113.05
USD
+1.71
+1.54%
Dec 20, 15:59 UTC -5
Closed
...

BioNTech SE - ADR Profile

About

BioNTech SE is a biotechnology company. It develops and commercializes immunotherapies for cancer and other diseases. BioNTech SE is based in Mainz, Germany.

Info & Links

CEO

Ugur Sahin

Headquarters

AN DER GOLDGRUBE 12
MAINZ, 2M 55131, GERMANY

Auditor

Ernst & Young GmbH

Share holders

--

Employees

6,133

BioNTech SE - ADR Statistics

Valuation Measures

Market Capitalization2

27.10B

Enterprise Value

16.79B

Enterprise Value/EBITDA(ttm)

-21.81

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

8.01

Price to Book(mrq)

1.26

Price to Cash(ytd)

21.96

Profitability

Gross Margin(ttm)

73.92%

Operating Margin(ttm)

-15.16%

Profit Margin(ttm)

-187.13%

Return on Equity(ttm)

-2.35%

Return on Invested Capital(ttm)

-2.46%

Return on Assets(ttm)

-2.05%

Income Statement

Revenue(ttm)

3.32B

Revenue Per Share(ttm)

--

Gross Profit(ttm)

2.80B

EBITDA(ttm)3

-769.72M

Net Income Available to Common(ttm)

-493.58M

Diluted EPS(ttm)

-2.10

Share Statistics

Beta (5Y Monthly)

0.22

52-Week Change

13.15%

S&P 500 52-Week Change

24.74%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

192.08M

% Held by Insiders

19.20%

% Held by Institutions

15.52%

Balance Sheet

Total Cash(mrq)

18.37B

Total Cash Per Share(mrq)

--

Total Debt(mrq)

267.97M

Total Debt/Equity(mrq)

1.27%

Current Ratio(mrq)

7.33%

Quick Ratio(mrq)

7.21%

Book Value Per Share(mrq)

87.67

Cash Flow

Operating Cash Flow Per Share(ytd)

3.02

Free Cash Flow(ytd)

496.58M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement